Effect of probiotics on small intestinal bacterial overgrowth in patients with gastric and colorectal cancer

Turkish Journal of Gastroenterology

Volumn 27, Issue 3, 2016, Pages 227-232

  Liang, Sufang ^a   Xu, Lin ^a   Zhang, Dongsheng ^a   Wu, Zhenjun ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Digestive diseases; Glucose hydrogen breath test; Malignancies; Proton pump inhibitors; Small intestinal bacterial overgrowth

Indexed keywords

PROBIOTIC AGENT; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; BACTERIAL OVERGROWTH; BIFIDOBACTERIUM; BREATH ANALYSIS; CASE CONTROL STUDY; CHINESE; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; SMALL INTESTINAL BACTERIAL OVERGROWTH; SMALL INTESTINE; STOMACH CANCER; BLIND LOOP SYNDROME; CHEMICALLY INDUCED; CHINA; COLORECTAL NEOPLASMS; MICROBIOLOGY; MIDDLE AGED; QUESTIONNAIRE; STOMACH NEOPLASMS; TREATMENT OUTCOME;

ADULT; AGED; BIFIDOBACTERIUM; BLIND LOOP SYNDROME; BREATH TESTS; CASE-CONTROL STUDIES; CHINA; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INTESTINE, SMALL; MALE; MIDDLE AGED; PROBIOTICS; PROTON PUMP INHIBITORS; STOMACH NEOPLASMS; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84968813728     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: 10.5152/tjg.2016.15375     Document Type: Article

References (37)

1. Ghoshal UC, Ghoshal U, Das K, Misra A. Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro-cecal transit time. Indian J Gastroenterol 2006; 25: 6-10
2. Konstantinov SR, Kuipers EJ, Peppelenbosch MP. Functional genomic analyses of the gut microbiota for CRC screening. Nat Rev Gastroenterol Hepatol 2013; 10: 741-5
3. Parracho H, McCartney AL, Gibson GR. Probiotics and prebiotics ininfant nutrition. Proc Nutr Soc 2007; 66: 405-11
4. Posserud I, Stotzer PO, Björnsson ES, Abrahamsson H, Simrén M. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007; 56: 802-8
5. King T. Small intestinal bacterial overgrowth and irritable bowel syndrome. JAMA 2004; 292: 2213-4
6. Gasbarrini A, Lauritano EC, Gabrielli M, et al. Small intestinal bacterial overgrowth: diagnosis and treatment. Dig Dis 2007; 25: 237-40
7. Saad RJ, Chey WD. Breath Testing for Small Intestinal Bacterial Overgrowth: Maximizing Test Accuracy. Clin Gastroenterol Hepatol 2013; S1542-3565: 1468-7
8. Pyleris E, Giamarellos-Bourboulis EJ, Tzivras D, Koussoulas V, Barbatzas C, Pimentel M. The prevalence of over-growth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome. Dig Dis Sci 2012; 57: 1321-9
9. Schiller LR. Evaluation of small bowel bacterial over-growth. Curr Gastroenterol Rep 2007; 9: 373-7
10. Rana SV, Sharma S, Kaur J, Sinha SK, Singh K. Comparing of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Digestion 2012; 85: 243-7
11. Bures J, Cyrany J, Kohoutova D, et al. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol 2010; 16: 2978-90
12. Wang Xiaohui, Yan Zhihui, Li Chao, et al. Clinical effect comparison between Bifidobaeterium triple viable capsules and Rifaximin onirritable bowel syndrome with small intestinal bacterial overgrowth. Acad J Chin PLA Med Sch 2015; 36: 970-2
13. He Xing, Wang Xiaohui, Yan Zhihui, et al. Efficacy of rifaximin and bifidobacterium triple viable capsules sequential therapy for smallintestinal bacterial overgrowth. Acad J Chin PLA Med Sch 2015; 36: 973-5
14. Choi YK, Kraft N, Zimmerman B, Jackson M, Rao SS. Fructose intolerance in IBS and utility of fructose-restricted diet.J Clin Gastroenterol 2008; 42: 233-8
15. Wang Wei, Liu Feng, Ailei Xu, et al. The study on small intestinal bacterial overgrowth in three kinds of digestive malignant tumors. J Med Rev 2011; 17: 946-7
16. Liu Yang, Li Yuan, Zhang Aijun, et al. The study on association between small intestinal cancer and small intestinal bacteria overgrowth along with its clinical meanings. WCJD 2013; 31: 3435-9
17. Liu Yang, Xu Lin. Significance of small intestinal bacterial overgrowth in patients with gastric cancer. Chin J Gastroenterol Hepatol 2015; 24: 354-6
18. Bustillo I, Larson H, Saif MW. Small intestine bacterial overgrowth: an underdiagnosed cause of diarrhea in patients with pancreatic cancer. JOP 2009; 10: 576-8
19. Kodach LL, Jacobs RJ, Voorneveld PW, et al. Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway. Gut 2011; 60: 1544-53
20. Schröder J, Wardelmann E, Winkler W, Fändrich F, Schweizer E, Schroeder P. Glutamine Dipeptide-supplemented Parenteral Nutrition Reverses Gut Atrophy, Disaccharidase Enzyme Activity, and Absorption in Rats. JPEN 1995; 19: 502-6
21. Xiaoming SU,Guiying Zeng,Dongqing Ren, et al. The influence of intestinal RNA on mesenteric lymph nodes bacterial translocation and endotoxin content in blood after 60 co gamma irradiation in mice. J Fourth Mil Med Univ 2006; 27: 860-2
22. Lombardo L, Foti M, Ruggia O, Chiecchio A. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin Gastroenterol Hepatol 2010; 8: 504-8
23. Jacobs C, Coss Adame E, Attaluri A, Valestin J, Rao SS. Dysmotility and ppi use are independent risk factors for small intestinal bacterial and/or fungal overgrowth. Aliment Pharmacol Ther 2013; 37: 1103-11
24. Vanderhoof JA, Pauley-Hunter RJ. Etiology and pathogenesis of small intestinal bacterial over growth [Internet]. Availablefrom:http://www.uptodate.com/contents/etiology-and-pathogenesis-ofsmall-intestinal-bacterial-overgrowth?-source=see_link
25. Laine L, Ahnen D, McClain C, Solcia E, Walsh JH. Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors. Aliment Pharmacol Ther 2000; 14: 651-68
26. Lo WK, Chan WW. Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis. Clin Gastroenterol Hepatol 2013; 11: 483-90
27. Sanduleanu S, Jonkers D, De Bruine A, Hameeteman W, Stockbrügger RW. Non-Helicobacter pylori bacterial flora during acidsuppressive therapy: differential findings in gastric juice and gastric mucosa. Aliment Pharmacol Ther 2001; 15: 379-88
28. Hoog CM, Lindberg G, Sjoqvist U. Findings in patients with chronic intestinal dysmotility investigated by capsule endoscopy. BMC Gastroenterol 2007; 7: 29
29. Vantrappen G, Janssens J, Hellemans J, Ghoos Y. The inter-digestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest 1977; 59: 1158-66
30. Barrett JS, Canale KE, Gearry RB, Irving PM, Gibson PR. Probiotie effects on intestinal fermentation patterns in patients with irritable bowel syndrome. World J Gastroenterol 2008; 14: 5020-4
31. Colecchia A, Vestito A, La Rocca A, et al. Symbiotic Study Group. Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome,constipation -variant. Results of flat open,uncontrolled muhieenter study. Minerva Gastroenterol Dietol 2006; 52: 349-58
32. Koo HL, DuPont HL. Rifaximin: a unique gastrointestinal selective antibiotic for enteric diseases. Curr Opin Gastroenterol 2010; 26: 17-25
33. Scarpellini E, Gabrielli M, Lauritano CE, et al. High dosage rifaximin for the treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2007; 25: 781-6
34. Khalighi AR, Khalighi MR, Behdani R, et al. Evaluating the efficacy of probiotic on treatment in patients with small intestinal bacterial overgrowth (SIBO) -A pilot study. Indian J Med Res 2014; 140: 604-8
35. Preidis GA, Versalovic J. Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterol 2009; 136: 2015-31
36. Quigley EM. Bacteria: a new player in gastrointestinal motility disorders-infections, bacterial overgrowth, and probiotics. GastroenterolClin North Am 2007; 36: 735-48
37. Spiller R. Review article: probiotics and prebiotics in irritable bowel syndrome. Aliment Pharmacol Ther 2008; 28: 385-96